TPTX stock was purchased by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Lord Abbett & CO. LLC, BlackRock Inc., Norges Bank, Credit Suisse AG, Candriam Luxembourg S.C.A., Jennison Associates LLC, and Federated Hermes Inc.. Company insiders that have bought Turning Point Therapeutics stock in the last two years include Athena Countouriotis, Brian Lee Baker, Carl L Gordon, Cormorant Asset Management, Lp, Simeon George, and Yi Larson.
View insider buying and selling activity for Turning Point Therapeutics or or view top insider-buying stocks.